Web-based roadmap for infertility treatment
The Effect of the Responsive Web-based Roadmap (InT-mAp) in Infertility Treatment on Women's Drug Administration, Treatment Success and Anxiety.
This study is testing a new online tool to help women under 35 who are having infertility treatments feel more informed and supported, with the hope of making their experience better and improving their chances of success.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 74 (estimated) |
| Ages | 18 Years to 35 Years |
| Sex | Female |
| Sponsor | Maltepe University Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT05890625 on ClinicalTrials.gov |
What this trial studies
This study aims to improve the treatment experience for women undergoing infertility treatments such as IVF and ICSI by utilizing a web-based application called InT-mAp. The application is designed to provide education and support to patients during the controlled ovarian hyperstimulation process, addressing issues related to anxiety and medication administration. By enhancing patient knowledge and confidence, the study seeks to reduce treatment interruptions and improve overall success rates. Participants will be women under 35 years old who are primary infertile and can effectively use mobile applications.
Who should consider this trial
Good fit: Ideal candidates for this study are women under 35 years old who are primary infertile and are undergoing IVF or ICSI treatments.
Not a fit: Patients with psychological or chronic illnesses that may affect treatment success or those who do not meet the eligibility criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the treatment experience and success rates for women undergoing infertility treatments.
How similar studies have performed: While this specific approach is novel, previous studies have indicated that educational interventions can positively impact treatment outcomes in infertility.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * In vitro fertilization-Embryo transfer (IVF-ET)/ Intracytoplasmic Sperm Injection (ICSI)-ET treatment planned as assisted reproduction treatment (ART) and who are in the controlled ovarian hyperstimulation (COS) process of the treatment, * Having no psychological or chronic illness and related treatment that may affect the success of treatment other than the cause of infertility, * Primary infertile, * Being under 35 years old, * Able to speak, read and write Turkish, perceive and answer questions correctly and communicate effectively, * Having a smart phone with Android and the operating system for i-Phone (IOS) operating systems, being able to use mobile applications, and having sufficient equipment to use these applications (internet, etc.), * Women who volunteered to participate in the study will be included in the sample. Exclusion Criteria: * Not meeting the sampling criteria, * Wanting to leave after the start of work, * Women with errors or deficiencies in their evaluation/use of the mobile application will be excluded from the study.
Where this trial is running
Istanbul
- SBÜ Zeynep Kamil Kadın ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi — Istanbul, Turkey (Recruiting)
Study contacts
- Study coordinator: Tugba Bozdemir
- Email: tugbabozdemir@maltepe.edu.tr
- Phone: +90 5520978860
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.